Revagenix
1 known investors
AMR-focused biopharma developing novel antibiotics for drug-resistant infections, initially targeting complex UTI.
1 known investors
AMR-focused biopharma developing novel antibiotics for drug-resistant infections, initially targeting complex UTI.